News | March 09, 2010

Percutaneous VAD Users Explain Cases at Symposium During ACC

March 9, 2010 – During the American College of Cardiology (ACC) 59th Annual Scientific Session, March 14-16, CardiacAssist will host its “Clinical Innovations in TandemHeart Support Symposium and User Group Meeting” from 6-8 p.m. Sunday, March 14, at the W Hotel Midtown, Altitude Room, 188 14th St. NE, in Atlanta.

Case presentations will be discussed by Nirat Beohar, M.D., Northwestern Memorial Hospital; Alan Gass, M.D., Westchester Medical Center; Navin Kapur, M.D., Tufts Medical Center; and Roy Small, M.D., Lancaster General Hospital. In anticipation of the TandemHeart clinical milestone of the 2,000th case, the symposium will focus on cutting-edge uses of the TandemHeart to treat critically ill patients who have a variety of cardiac conditions. Attendees will learn “tips and tricks” from the some of the most progressive TandemHeart physicians. Current and prospective TandemHeart users are encouraged to attend the symposium and user group meeting.

The event is by invitation only. To RSVP for the event, contact Monica Bush at (412) 963-7770, Ext. 247, or by e-mail at [email protected]

FDA-cleared TandemHeart can be placed rapidly by both interventional cardiologists in a cath lab and by cardiac surgeons in an operating room. Hemodynamic support includes a net blood-flow rate of up to 5 liters per minute in the catheterization lab or up to 8 liters per minute in the OR.

For more information: www.cardiacassist.com

Related Content

Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
Technology | Ventricular Assist Devices (VAD) | July 17, 2018
Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for a less-invasive implant approach...
CorWave's Next-generation Neptune LVAD Receives Funding

Image courtesy of CorWave

News | Ventricular Assist Devices (VAD) | July 11, 2018
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new...
Abbott Recalls the HeartMate 3 Left Ventricular Assist System, LVAD
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
FDA Approves Abiomed Impella CP With SmartAssist and Optical Sensor
Technology | Ventricular Assist Devices (VAD) | April 02, 2018
Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its...
Reduced Device Clotting, Decreased Strokes Seen With HeartMate 3 at Two Years
News | Ventricular Assist Devices (VAD) | March 13, 2018
At two years of follow-up, severely ill patients with advanced heart failure who received a novel heart pump fully...
Medtronic HeartWare HVAD System Approved for Destination Therapy
Technology | Ventricular Assist Devices (VAD) | October 04, 2017
October 4, 2017 — Medtronic received U.S.
Abiomed Receives FDA PMA Approval for Impella RP for Right Heart Failure
Technology | Ventricular Assist Devices (VAD) | September 28, 2017
Abiomed Inc. recently received U.S. Food and Drug Administration (FDA) pre-market approval (PMA) for the Impella RP ...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD) | August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Pre-PCI Impella 2.5 Insertion Improves Survival in Left Main Coronary Artery Heart Attacks
News | Ventricular Assist Devices (VAD) | June 30, 2017
Abiomed Inc. announced the recent publication of a peer-reviewed retrospective study on hemodynamic support with the...
Overlay Init